Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Silicon containing doai
Patent
1994-07-06
1996-06-04
Robinson, Allen J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Silicon containing doai
424724, A61K 31695, A61K 3300
Patent
active
055232957
ABSTRACT:
A method for treating or preventing Alzheimer's disease in a mammal is described. A silicon compound for inhibiting interaction between aluminum and .beta.-amyloid or neurofilament protein is provided. The silicon compound is administered to a mammal in need of such treatment to cause this inhibition to occur.
REFERENCES:
patent: 5242932 (1993-09-01), Gandy et al.
patent: 5385915 (1995-01-01), Buxbaum et al.
Edwardson J. A. et al, "Effect of Silicon on Gastrointestinal Absorption of Aluminum", Biosis, No. 93: 416445 (1993).
Fasman, G. D. and C. D. Moore, "The solubilization of model Alzheimer tangles: Reversing the .beta.-sheet conformation induced by aluminum with silicates", Proc. Natl. Acad. Sci. USA, 91:11232-11235 (1994) (I).
Fasman, G. D. et al., "Solubilization of .beta.-amyloid-(1-42)-peptide: Reversing the .beta.-sheet conformation induced by aluminum with silicates", Proc. Natl. Acad. Sci. USA, 92:(in press) (1995) (II).
Schwarz, K. and D. B. Milne, "Growth-promoting Effects of Silicon in Rats", Nature, 239:333-334 (1972).
Perry, G. and M. A. Smith, "Senile Plaques and Neurofibrillary Tangles: What Role Do They Play in Alzheimer's Disease?", Clinical Neuroscience, 1:199-203 (1993).
Henig, R. M., "Is Misplacing Your Glasses Alzheimer's?", New York Times Magazine (Apr. 24, 1994).
Markeshery W. R. and W. D. Ehmann, "Aluminum and Alzheimer's Disease", Clinical Neuroscience, 1:212-218 (1993).
Goedert, M. et al., "Neurofibrillary tangles and .beta.-amyloid deposits in Alzheimer's disease", Current Opinion in Neuro-biology, 1:441-447 (1991).
Edwardson, J. A. et al., "Aluminosilicates and the ageing brain: implications for the pathogenesis of Alzheimer's disease", Silicon Biochemistry, Ciba Foundation Symposium 121 (Ed. D. Evered and M. O'Connor), Wiley, pp. 160-179 (1986).
Naylor, G. J. et al., "Raised serum aluminum concentration in Alzheimer's disease", Trace Elements in Medicine, 6(3):93-95 (1989).
Banin, E. and H. Meiri, "Toxic Effects of Alumino-Silicates on Nerve Cells", Neuroscience, 39(1):171-178 (1990).
Martin, R. B., "Aluminosilicate Stabilities Under Blood Plasma Conditions", Polyhedron, 9(23):193-197 (1990).
Good, P. F. et al., "Selective Accumulation of Aluminum and Iron in the Neurofibrillary Tangles of Alzheimer's Disease: A Laser Microprobe (LAMMA) Study", Ann. Neurol., 31:286-292 (1992) (I).
Leterrier, J. F. et al., "A Molecular Mechanism for the Induction of Neurofilament Bundling by Aluminum Ions", J. Neurochem. 58:2060-2070 (1992).
Good, P. F. and D. P. Perl, "Aluminium in Alzheimer's?", Nature, 362:418 (1993) (II).
Eichhorn, G. L., "Is There Any Relationship Between Aluminum and Alzheimer's Disease?", Experimental Gerontology, 28:493-498 (1993).
Wisniewski, H. M. and G. Y. Wen, "Aluminium and Alzheimer's disease", Aluminium in biology and medicine, Ciba Foundation Symposium 169, Wiley, Chichester, pp. 142-164 (1992).
Lovell, M. A. et al., "Laser Microprobe Analysis of Brain Aluminum in Alzheimer's Disease", Ann. Neurol. 33:36-42 (1993).
Landsberg, J. P. et al., "Absence of aluminium in neuritic plaque cores in Alzheimer's disease", Nature, 360:65-68 (1992) (I).
Kruck, T. P. A., "Aluminium--Alzheimer's Link?", Nature, 363:119 (1993).
Landsberg, J. P. et al., "Alzheimer's response", Nature 364:294 (1993) (II).
Epstein, S. G., "Aluminum Intake and Its Effects", in Geochemistry and Health, Ed. I. Thornton et al., Science Reviews Ltd., Northwood; Antony Rowe Ltd.; Chippenham, Wiltshire, pp. 189-200 (1988).
Jones, K. C., "Human Exposure to Environmental Aluminium", in Geo-chemistry and Health, Ed. I. Thornton et al., Science Reviews Ltd., Northwood; Antony Rowe Ltd.; Chappenham, Wiltshire, pp. 243-244 (1988).
Flaten, T. P., "Geographical Associations between Aluminium in Drinking Water and Registered Death Rates with Dementia (including Alzheimer's Disease) in Norway", in Geochemistry and Health, Ed. I. Thornton et al., Science Reviews Ltd., Northwood; Antony Rowe Ltd.; Chappenham, Wiltshire, pp. 245-256 (1988).
Vogt, T., "A Possible Relationship between Aluminium in Drinking Water and Alzheimer's Disease in Southern Norway", in Geo-chemistry and Health, Ed. I. Thornton et al., Science Reviews Ltd., Northwood; Antony Rowe Ltd., Chippenham, Wiltshire, pp. 257-266 (1988).
Martyn, C. N. et al., "Geographical Relation Between Alzheimer's Disease and Aluminium in Drinking Water", The Lancet, pp. 59-62 (14 Jan. 1989).
McLachlan, D. R. Crapper et al., "Would decreased aluminum ingestion reduce the incidence of Alzheimer's disease?", Can. Med. Assoc. J. 145(7):793-804 (1991).
Doll, Sir Richard, "Review: Alzheimer's Disease and Environmental Aluminum", Age and Ageing, 22:138-153 (1993).
Carlisle, E. M. et al., "Effect of Dietary Silicon and Aluminum on Silicon and Aluminum Levels in Rat Brain", Alzheimer Disease and Associated Disorders, 1(2):83-89 (1987).
Birchall, J. D., "The Toxicity of Aluminium and the Effect of Silicon on its Bioavailability", Aluminium in Chem. Biol. and Med., 1:53-69 (1991) (I).
Dobbie, J. W. and M. J. B. Smith, "Urinary and serum silicon in normal and uraemic individuals", Silicon Biochemistry, Ciba Foundation Symposium 121, (Ed. D. Evered and M. O'Connor), Wiley, pp. 194-213 (1986).
Hench, L. L. and J. Wilson, "Biocompatibility of silicates for medical use", Silicon Biochemistry, Ciba Foundation Symposium 121, (Ed. D. Evered and M. O'Connor), Wiley, pp. 231-246 (1986).
Misra, V. et al., "Binding of Silicic Acid by Proteins and its Relation to Toxicity of Silicate Dusts", J. Applied Toxicology, 3(3):135-138 (1983).
Birchall, J. D. and J. S. Chappell, "The Solution Chemistry of Aluminium and Silicon and Its Biological Significance", in Geo-chemistry and Health, Ed. I. Thornton et al., Science Reviews Ltd., Northwood; Antony Rowe Ltd.; Chippenham, Wiltshire, pp. 231-242 (1988) (II).
Birchall, J. D. and J. S. Chappell, "The Chemistry of Aluminum and Silicon in Relation to Alzheimer's Disease", Clin. Chem., 34(2):265-267 (1988) (III).
Berthon, G., "Relevance of aluminium-acid complex equilibria to aluminium bioavailability", Metal Ions in Biology and Medicine, 2:253-258 (1992).
Birchall, J. D., et al., "Acute toxicity of aluminium to fish eliminated in silicon-rich acid waters", Nature, 338:146-148 (1989) (IV).
Schehr, R. S., "Therapeutic Approaches to Alzheimer's Disease", Bio/Technology, 12:140-144 (1994).
Stevenson, R., "Drug leads begin to penetrate Alzheimer gloom", Chemistry in Great Britain, pp. 165-167 (1994).
Hanin, I., "A Survey of Current Treatment Strategies in Alzheimer's Disease," Drugs in Development, 2:195-200 (1993).
Owens, N. J., "Focus on tacrine HCl", Hosp. Formul., 28:679-688 (1993).
Birchall, J. D. and J. S. Chappell, "Aluminium, Water, Chemistry, and Alzheimers's Disease", The Lancet, p. 253, Apr. 29, 1989 (V).
Amberla, K. et al., "Long-term treatment with tacrine (THA) in Alzheimer's disease--evaluation of neuropsychological data", Acta Neurol. Scand., 149(S):55-57 (1993).
Maltby, N. et al., "Efficacy of tacrine and lecithin in mild to moderate Alzheimer's disease: double blind trail", BMJ, 308: 879-883.
Knapp, M. J. et al., "A 30-Week Randomized Controlled Trial of High-Dose Tacrine in Patients With Alzheimer's Disease", JAMA, 271:985-991 (1994).
Otvos, Jr., L. et al., "Phosphorylation Loops in Synthetic Peptides of the Human Neurofilament Protein Middle-Sized Subunit", J. Protein Chemistry, 7:365-376 (1988) (I).
Hollosi, M. et al., "Metal Ion-induced Conformational Changes of Phosphorylated Fragments of Human Neurofilament (NF-M) Protein", J. Mol. Biol. 223:673-682 (1992) (I).
Hollosi, M. et al., "CA.sup.2+ -Induced Conformational Transitions of Phosphorylated Peptides", Biopolymers, 33:497-510 (1993) (II).
Holly, S. et al., "FT-IR Spectroscopy Indicates that Ca.sup.2+ -Binding to Phosphorylated C-Terminal Fragments of the Midsized Neurofilament Protein Subunit Results in .beta.-Sheet Formation and .beta.-Aggregation," Biochemical and Biophysical Research Communications, 197:755-762 (1993).
Shen, Z. M. et al., "Study of Al.sup.3+ Binding and Conformational Properties of the Alanine-Substituted C-Terminal Domain of the
Brandeis University
Lambkin Deborah
Robinson Allen J.
LandOfFree
Method for treating and preventing alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating and preventing alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating and preventing alzheimer's disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-383421